ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO1005

Impact of the Serum Sodium and Chloride Difference on All-Cause Mortality in Japanese Hemodialysis Patients: The Miyazaki Dialysis Cohort Study

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Toida, Tatsunori, University of Miyazaki, Miyazaki, Miyazaki, Japan
  • Sato, Yuji, University of Miyazaki Hospital, Miyazaki, Miyazaki, Japan
  • Kitamura, Kazuo, Department of Internal Medicine, Circulatory and Body Fluid Regulation, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
  • Fujimoto, Shouichi, University of Miyazaki, Miyazaki, Miyazaki, Japan
Background

Few studies have examined the relationship between the acid-base balance and mortality in hemodialysis patients. In actual clinical settings, the regular collection of blood gas data is rarely conducted. In theory, the serum sodium and chloride difference (SCD) is equal to the anion gap plus bicarbonate, and we herein investigated whether SCD as a simple acid-base balance index affected the risk of mortality in maintenance hemodialysis patients.

Methods

Study design: Cohort study.
Setting, Participants: Data from the Miyazaki Dialysis Cohort study, including 1113 hemodialysis patients aged ≥18 years, dialysate sodium 140 mEq/L, with SCD pre- and post-dialysis.
Predictors: Pre-dialysis SCD, <33, 33 to 35, 35 to 37, ≥37 (reference), and post-dialysis SCD <36, 36 to 37, 37 to 39, ≥39 (reference) according to quartiles.
Outcomes: All-cause mortality during a 2-year follow-up.
Measurements: The crude mortality rate in each group was assessed using a Kaplan–Meier analysis with the Log-rank test. Hazard ratios (HRs) were estimated using Cox’s model for the relationships between SCD categories and mortality, and adjusted for potential confounders. Patients in the higher group were set as our reference category.

Results

Among the 1113 patients in this cohort study (median age [interquartile range], age 69 [59-77] years, dialysis vintage 72 [34-141] months, and females 42.7%), 154 patients died during the follow-up. The Kaplan-Meier analysis showed that the survival rate was significantly lower in patients in the lowest SCD (<36) group post-dialysis than in those in the other groups (Log-rank test, P<0.01), whereas no significant differences were observed pre-dialysis (Log-rank test, P=0.26). Cox’s regression analysis showed that the lowest SCD (<36) group post-dialysis was independently associated with an increased risk of mortality (adjusted HR [95% CI] 2.01 [1.25-3.23]). No relationship was observed between pre-dialysis SCD levels and all-cause mortality.

Conclusion

Among Japanese maintenance hemodialysis patients, low SCD levels post-dialysis, but not pre-dialysis, increased the risk of mortality. The present results suggest that SCD post-dialysis is a predictor of mortality.